
GLP-1 receptor agonist
Liraglutide
GLP-1 receptor agonist. Supplied for laboratory research use only.
- GLP-1 agonist; FDA-approved as Victoza (2010), Saxenda (2014)
- Also approved by EMA and TGA for equivalent uses
- Supplied for laboratory research use only. Not for human or veterinary use.
90-Day Money-Back Guarantee
Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.
Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.
What it is
Development status
Liraglutide is approved by the FDA as a prescription medicine. FDA approved as Victoza (type 2 diabetes, Jan 2010) and Saxenda (chronic weight management, Dec 2014). This product is not that medicine and is supplied for laboratory research use only.
Development status is stated above. No efficacy claim is made on this page.
Shipping & returns
The specifics
The details, if you want them.
Development
Where it is up to.
Peer-reviewed and the basis for FDA/EMA/MHRA/TGA approval as Victoza and Saxenda. This vial is a separate, unapproved research product, not those medicines.
Questions
The questions people actually ask.
What is liraglutide?
Is this the same as Victoza or Saxenda?
What does "Research Use Only" mean?
How is this vial supplied?
What is your refund policy?